Found: 9
Select item for more details and to access through your institution.
Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 10, p. 605, doi. 10.1159/000449024
- By:
- Publication type:
- Article
First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 6, p. 553, doi. 10.1007/s40261-018-0629-1
- By:
- Publication type:
- Article
Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation р.T632I.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 1, p. 109, doi. 10.1159/000495782
- By:
- Publication type:
- Article
Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10530, doi. 10.3390/ijms241310530
- By:
- Publication type:
- Article
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4868, doi. 10.3390/ijms24054868
- By:
- Publication type:
- Article
Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 2, p. 307, doi. 10.1007/s10549-023-07135-3
- By:
- Publication type:
- Article
Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 192, n. 2, p. 283, doi. 10.1007/s10549-022-06517-3
- By:
- Publication type:
- Article
Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 3, p. 731, doi. 10.1007/s10549-019-05492-6
- By:
- Publication type:
- Article
Strong founder effect for BRCA1 c.3629_3630delAG pathogenic variant in Chechen patients with breast or ovarian cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 3167, doi. 10.1002/cam4.5159
- By:
- Publication type:
- Article